Project Grant R21ES036419
Award Date
6/6/25
Completion Date
5/31/27
Dollars Obligated
$236K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute of Environmental Health Sciences
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $445,500.00 to the University of Alabama at Birmingham (UAB) to study the role of proteolytic extracellular vesicles in chronic lung injury following exposure to chlorine (Cl2) or bromine (Br2) gas. The key objectives are to determine the involvement of neutrophil-derived extracellular vesicles containing neutrophil elastase in...
The National Institutes of Health (NIH) Office of the Director awarded the University of Wisconsin System a Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to develop medical countermeasures for chlorine exposure. The $226,464 award, effective June 11, 2025 through May 31, 2027, aims to investigate the therapeutic efficacy of GABA(A) receptor modulators in reducing acute lung injury caused by inhaled chlorine. Specifically, the research will: 1) determine the therapeutic...
The Project Grant award R56ES034423 from the Department of Health and Human Services National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) provides $445,500 to the University of Alabama at Birmingham (UAB) to study the role of extracellular vesicles (EVs) and exosomes as mediators of injury from inhaled exposures to toxic chemicals such as sulfur mustard and chlorine. The project aims to: (A) characterize EVs/exosomes derived from the bronchoalveolar lavage fluid...
This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health program (CFDA 93.113) is supporting research on the role of endogenous docosahexaenoic acid (DHA) in resolving ozone-induced lung inflammation. The $282,169 award to The Ohio State University, which will run from August 2024 to May 2025, aims to examine how endogenous DHA synthesis in alveolar macrophages reduces ozone-induced pulmonary inflammation and promotes...
This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $262,093 to investigate the role of the ACOD1-itaconate immunometabolic pathway in regulating lung monocyte/macrophage inflammatory processes in environmental exposure-induced lung disease. The research aims to: 1) determine the functional effects of the ACOD1-itaconate pathway on human monocyte-derived macrophage differentiation...
This $322,328 Project Grant was awarded by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) federal grant program. The grant will support research to (1) assess the prevalence, predictors, and potential exposure sources of per- and polyfluoroalkyl substances (PFAS) among U.S. volunteer firefighters, and (2) examine associations between PFAS levels and dyslipidemia (blood lipid imbalances) in this population. The project leverages data...
This federal Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $555,283 to Duke University to conduct research aimed at identifying and optimizing medical countermeasures for phosgene gas-induced lung injuries. The research project has three key objectives: 1) Screen the efficacy of renin-angiotensin-aldosterone system (RAAS) modulators and soluble epoxide hydrolase inhibitors...
The National Institute of Environmental Health Sciences (NIEHS) awarded a $431,750 Project Grant under the Environmental Health (CFDA 93.113) program to the University of California, Irvine (UC Irvine) for the period of January 9, 2025 to January 8, 2027. The project aims to identify a new innate immune signaling mechanism triggered by DNA lesions that impede transcription, allowing cells to alert neighboring cells of potential dangers and recruit immune cells without relying solely on gene...
This federal Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), provides $414,979 to the University of Washington to elucidate the mechanisms of ferroptosis, a regulated form of cell death, mediated by nonconjugated and conjugated polyunsaturated fatty acids. The research aims to determine the spatial distribution and progression of lipid peroxidation in...
This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health (CFDA 93.113) program, totaling $749,901.00, aims to elucidate the origins of mutational landscapes in cancer development. The project will adopt a synergistic approach integrating cellular DNA adductomics, nanopore sequencing, and single-molecule duplex sequencing to characterize DNA lesions and mutational outcomes. The research focuses on three environmental...